Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.6990
-0.0116 (-1.63%)
At close: Jun 8, 2026, 4:00 PM EDT
0.7300
+0.0310 (4.43%)
Pre-market: Jun 9, 2026, 5:02 AM EDT
Dyadic International Revenue
Dyadic International had revenue of $1.11M in the quarter ending March 31, 2026, with 182.28% growth. This brings the company's revenue in the last twelve months to $3.81M, up 7.13% year-over-year. In the year 2025, Dyadic International had annual revenue of $3.09M, down -11.59%.
Revenue (ttm)
$3.81M
Revenue Growth
+7.13%
P/S Ratio
6.69
Revenue / Employee
$761,546
Employees
5
Market Cap
25.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.09M | -405.04K | -11.59% |
| Dec 31, 2024 | 3.50M | 596.58K | 20.58% |
| Dec 31, 2023 | 2.90M | -31.49K | -1.07% |
| Dec 31, 2022 | 2.93M | 526.47K | 21.90% |
| Dec 31, 2021 | 2.40M | 801.91K | 50.06% |
| Dec 31, 2020 | 1.60M | -79.16K | -4.71% |
| Dec 31, 2019 | 1.68M | 385.63K | 29.77% |
| Dec 31, 2018 | 1.30M | 537.03K | 70.81% |
| Dec 31, 2017 | 758.42K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Celularity | 26.55M |
| Barinthus Biotherapeutics | 14.97M |
| Kyntra Bio | 7.44M |
| CervoMed | 2.09M |
| Pluri | 1.08M |
| Allarity Therapeutics | 345.00K |
DYAI News
- 11 days ago - Dyadic International Transcript: Lytham Partners Spring 2026 Investor Conference - Transcripts
- 11 days ago - Dyadic International, Scripps Research team to evaluate Hantavirus vaccine - TheFly
- 11 days ago - Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development - GlobeNewsWire
- 18 days ago - Dyadic to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 - GlobeNewsWire
- 18 days ago - Skyline Corporate Communications Group, LLC Announces Dyadic Applied BioSolutions to Deliver a Live Presentation at the Skyline Signature Series™ on Wednesday, May 27 at 12:00 PM ET - GlobeNewsWire
- 19 days ago - Dyadic International Transcript: Sidoti Micro-Cap Virtual Conference - Transcripts
- 20 days ago - Dyadic Applied BioSolutions Announces Participation in Sidoti Virtual Investor Conference - GlobeNewsWire
- 20 days ago - Dyadic International Slides: Investor presentation - Filings